Stop by booth 1314 to discover a new way to treat insomnia
Ebb Therapeutics (previously Cerêve Inc.)
SLEEP2017 marks the introduction of ebb™ insomnia therapy, the first clinically-proven, FDA-cleared device to reduce sleep latency (to Stage 1 and Stage 2 sleep) in patients with primary insomnia. Stop by booth 1314 to hear the clinical story and experience the only wearable, drug-free therapy for insomnia.
Brands: Ebb Insomnia Therapy